2Sparsa A. Eczema eraquele [ J ]. Annales De Dermatologie Et De Vnr6ologie, 2011, 138(8 -9) : 622.
3Darsow U. Allergen - specific immunotherapy for atopic eczema : updated [ J ]. Current Opinion In Allergy And Clinical Immunolo- gy, 2012, 12(6) : 665 -669.
4Morton L, Phillips T. Venous eczema and lipodermatosclerosis [J]. Seminars In Cutanems Medicine And Surgery, 2013, 32 (3): 169-176.
5Eyerich K, Novak N. Immunology of atopic eczema: overcoming the Thl/Th2 paradigm [Jl. Allergy, 2013, 68 (8): 974- 982.
6Simon D, Kozlowski E, Simon H. Natural killer T cells express- ing IFN - gamma and IL - 4 in lesional skin of atopic eczema [J]. Allergy, 2009, 64(11): 1681 -1684.
7Bossowski A, Harasymezuk J, Moniuszko A, et al. Cytomctrit. evaluation of intracelluiar IFN - γ and IL - 4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases [ J ]. Thyroid Research, 2011, 4 ( 13 ) :912 - 917.
8Abrahamsson T, Sandberg Abelius M, Forsberg A, et al. A Thl/Th2 - associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization [ J ]. Clinical And Experimental .Allergy, 2011 , 41 (12) : 1729 - 1739.
9Miyake Y, Tanaka K, Arakawa M. Case - control study of ec- zema in relztion to liARs genetic polymorphisnts in Japanese women: The Kyusbu Okinawa Maternal and Child Health Study [ J]. Scandinavian Journal Of Immtmology, 2013, 77 (5) : 413 -418.
